Modulation of the Metabiome by Rifaximin in Patients with Cirrhosis and Minimal Hepatic Encephalopathy

Modulation of the Metabiome by Rifaximin in Patients with Cirrhosis and Minimal Hepatic Encephalopathy

Hepatic encephalopathy (HE) represents a dysfunctional gut-liver-brain axis in cirrhosis which can negatively impact outcomes. This altered gut-brain relationship has been treated using gut-selective antibiotics such as rifaximin, that improve cognitive function in HE, especially its subclinical for...

Full description

Bibliographic Details
Main Authors: Bajaj, Jasmohan S., Heuman, Douglas M., Sanyal, Arun J., Hylemon, Phillip B., Sterling, Richard K., Stravitz, R. Todd, Fuchs, Michael, Ridlon, Jason M., Daita, Kalyani, Monteith, Pamela, Noble, Nicole A., White, Melanie B., Fisher, Andmorgan, Sikaroodi, Masoumeh, Rangwala, Huzefa, Gillevet, Patrick M.
Format: Online
Language:English
Published: Public Library of Science 2013
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3615021/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3615021/

Similar Items